U.S. FDA clears version 2.0 of Abbott's low-cost glucose monitor By: Reuters: Company News June 15, 2020 at 07:17 AM EDT The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device. Read More >>